Exploratory study about risk factors of respiratory complications in invasive trans oral with combined use of exhaled CO2 concentration measurement and patient awakening measurement

Not Applicable

• Conditions: pper gastrointestinal bleeding/tumor

• Registration Number: JPRN-UMIN000036269
• Lead Sponsor: Keio University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2019-03-23
• Study Completion: 2020-12-31
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

Not provided

Exclusion Criteria

Patients who disagree with this study.

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Hypoxemia (SpO2 <90% lasts more than 15 seconds)

Secondary Outcome Measures

Name	Time	Method
Apnea (exhaled CO2 detection continues for more than 15 seconds),Vital abnormality(Hypotension (systolic blood pressure 90 mmHg or less lasts more than 1 minute), Bradycardia (50 pulses per minute or less lasting more than 1 minute)), Type of examination, Procedure related items (examination time, total sedative dose, total oxygen dose),Severe hypoxemia (SpO2 <85% lasts more than 15 seconds), Serious complications (pneumonia requiring oxygen administration, bleeding requiring blood transfusion, perforation of digestive tract etc.), Patient satisfaction (Numerical Rating Scale (NRS) 10 stages (questioned by nurse in recovery room after examination), cooperation of patients by implementation doctor evaluation (NRS 10 grade)